L1CAM and endometrium neoplasm: The immunohistochemical (IHC) detection of L1CAM in endometrial tumor samples seems to be able to discriminate a subset of highly aggressive tumors with high risk of distant recurrences [6] and to assess the risk of pelvic lymph-node involvement [7].